NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00101205 2014-02-24Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated40 enrolled
NCT00472849 2013-11-26Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and LeukemiasM.D. Anderson Cancer CenterPhase 1/2 Completed92 enrolled 7 charts
NCT00006473 2013-01-23Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Completed72 enrolled
NCT00452374 2011-11-02Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLLM.D. Anderson Cancer CenterPhase 1/2 Completed48 enrolled 6 charts
NCT00470405 2011-04-18Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or LymphomaVanderbilt-Ingram Cancer CenterPhase 1 Completed25 enrolled